Virtual for Care Atrial Fibrillation Patients Using VIRTUES
NCT ID: NCT04599114
Last Updated: 2020-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
300 participants
INTERVENTIONAL
2020-11-01
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer Simulated Atrial Fibrillation Tool
NCT03080857
AF at Home: A Virtual Education Program for Patients With Atrial Fibrillation (AF)
NCT05810896
Discerning Symptomatic and Asymptomatic Episodes Pre and Post Radiofrequency Ablation of Atrial Fibrillation
NCT00745706
Patient Centered Mobile Health Technology Enabled Atrial Fibrillation Management
NCT05400837
Atrial Fibrillation and Congestive Heart Failure Trial
NCT00597077
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VIRTUES Arm
Patients in the VIRTUES arm will be offered enrollment into the virtual atrial fibrillation care platform.
VIRTUES
VIRTUES is a digital health platform that offers 2 way communication between clinicians and patients to address symptoms stemming from atrial fibrillation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VIRTUES
VIRTUES is a digital health platform that offers 2 way communication between clinicians and patients to address symptoms stemming from atrial fibrillation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* documented symptomatic new-onset or pre-existing, non-valvular AF
* ER visit or hospitalization for primary AF in the last 6 months
* proficient in the English language
Exclusion Criteria
* planning to move/relocate during the period of study
* current pregnancy
* patient is a prisoner/incarcerated
* no access to a smart device with Bluetooth capabilities
* planned percutaneous coronary intervention, coronary artery bypass graphing or heart valve surgery within the next year
* any medical condition making 1 year survival unlikely
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cardiac Arrhythmia Network of Canada
OTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Allan Skanes
Director, Electrophysiology Laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Allan C Skanes, Md
Role: PRINCIPAL_INVESTIGATOR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
Rachel Caris
London, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ratika Parkash, MD
Role: primary
Dana Murray, BScN
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4411
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.